Results for tag: "Nerve Sheath Tumor Drug"

Nerve Sheath Tumors (NSTs) are a type of cancer that affects the cells that form the protective covering of nerves. NSTs are rare and can occur in any part of the body. Treatment for NSTs typically involves surgery, radiation therapy, and chemotherapy. Oncology drugs are used to treat NSTs, and the Nerve Sheath Tumor Drug market is a subset of the larger Oncology Drug market. The Nerve Sheath Tumor Drug market is composed of a variety of drugs used to treat NSTs. These drugs are used to reduce the size of tumors, reduce pain, and improve quality of life. Common drugs used to treat NSTs include temozolomide, vincristine, and carboplatin. The Nerve Sheath Tumor Drug market is highly competitive, with many companies offering drugs to treat NSTs. Some of the companies in the market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more